Evidence map›Paper›PMID 35071527›Full record

ArticleWorld journal of clinical cases2022

Hyper-accuracy three-dimensional reconstruction as a tool for better planning of retroperitoneal liposarcoma resection: A case report.

Mu-Shi Ye, Hao-Kai Wu, Xing-Zhang Qin, Fan Luo, Zhuo Li

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mu-Shi YeLaboratory of Urology, The Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou 524001, Guangdong Province, China.
Hao-Kai WuLaboratory of Urology, The Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou 524001, Guangdong Province, China.
Xing-Zhang QinLaboratory of Urology, The Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou 524001, Guangdong Province, China.
Fan LuoLaboratory of Urology, The Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou 524001, Guangdong Province, China.
Zhuo LiLaboratory of Urology, The Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Guangzhou 524001, Guangdong Province, China. zhuosal@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWell-differentiated liposarcoma is the second most common pathologic type of retroperitoneal sarcoma. It is characterized by a huge mass, but multiple organ invasions are common. Surgery is the only treatment option for potential cure. Hyper-accuracy three-dimensional (3D) reconstruction is widely used in robotic partly nephrectomy owing to its ability to visualize overlapping anatomy. CASE SUMMARY: A 54-year-old man was admitted for progressive abdominal distension over the preceding 2 mo. Computed tomography revealed a 32 cm × 21 cm × 12 cm lipomatous mass. Hyper-accuracy 3D reconstruction was performed because of the complex relationship between the mass and nearby tissue. The patient underwent surgical resection, and the tumor did not recur for over 16 mo.

conclusionHyper-accuracy 3D reconstruction is useful for operative planning owing to its intuitiveness and precise determination of anatomical structures in both tumors and nearby tissues.

Indexed as

Case reportHyper-accuracy three-dimensional reconstructionSurgical resectionWell-differentiated liposarcoma

Identifiers

PMID35071527
PMCPMC8727265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.